As of Dec 20, 2024, the Dexcom stock's P/E ratio is 46.0. This takes into account the latest EPS of $1.74 and stock price of $80.04. The PE ratio has decreased by 34% from its last 4 quarters average of 69.4.
The PE ratio of Dexcom has averaged 130.88 over the last seven years. The current price-to-earnings ratio of 46.0 is 65% less than the historical average. Analyzing the last seven years, DXCM's PE ratio reached its highest point in the Sep 2018 quarter at 298, when the price was $35.76 and the EPS was $0.12. The lowest point was recorded in the Sep 2024 quarter, when it reached 38.53 with a price of $67.04 and an EPS of $1.74.
Maximum annual increase: 278.63% in 2021
Maximum annual decrease: -67.58% in 2020
Year | PE ratio | Change |
---|---|---|
2023 | 88.64 | -31.12% |
2022 | 128.68 | -46.32% |
2021 | 239.71 | 278.63% |
2020 | 63.31 | -67.58% |
2019 | 195.3 | N/A |
2018 | N/A | N/A |
2017 | N/A | N/A |
2016 | N/A | N/A |
2015 | N/A | N/A |
2014 | N/A | N/A |
DXCM's current PE ratio is under its 3, 5 and 10-year averages.
DXCM's PE ratio is less than its peer stock WST, but it is above JNJ's and ABT's. Dexcom's current PE ratio of 46.0 is more than the average of its peers, which is 30.23.
Stock name | PE ratio | Market cap |
---|---|---|
EW Edwards Lifesciences Corp | 10.78 | $44.12B |
JNJ Johnson & Johnson | 23.96 | $347.83B |
MDT Medtronic plc | 24.63 | $103.9B |
ABT Abbott Laboratories | 34.62 | $198.13B |
BDX Becton Dickinson & Co | 38.72 | $65.83B |
DXCM Dexcom Inc | 46 | $31.26B |
WST West Pharmaceutical Services Inc | 48.66 | $24B |
TNDM Tandem Diabetes Care Inc | N/A | $2.36B |
QDEL Quidel Corp | N/A | $3.02B |
The price to earnings ratio for DXCM stock is 46 as of Dec 20, 2024.
As an average over the last 3 years, DXCM stock has a PE ratio of 122.93.
As an average over the last 5 years, DXCM stock has a PE ratio of 122.52.
Over the last seven years, the quarterly PE ratio reached its highest level at 298 in the Sep 2018 quarter.
DXCM's price to earnings ratio is currently 65% below its 7-year historical average.
The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Dec 20, 2024), Dexcom's share price is $80.04. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $1.74. Therefore, Dexcom's price to earnings ratio for today is 46. PE RATIO(46) = STOCK PRICE($80.04) / TTM EPS($1.74)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.